医学
癌胚抗原
实体瘤疗效评价标准
结直肠癌
危险系数
单变量分析
多元分析
转移
化疗
内科学
肿瘤科
肝切除术
放射科
癌症
进行性疾病
切除术
外科
置信区间
作者
Mitsuhiro Katagiri,Tomoya Sudo,TATSUYUKI TOUNANN,Tatsuyuki Kakuma,Susumu Shimomura,Sachiko Nagasu,Kensuke Tajiri,Shinya Fujino,Koutarou Yuge,Hidetaka Murakami,Keisuke Miwa,Toru Hisaka,Fumihiko Fujita,Yoshito Akagi
标识
DOI:10.21873/anticanres.16567
摘要
Hepatic recurrences after resection of metastatic lesions in advanced colorectal cancer (CRC) have an enormous impact on patient prognosis. Response evaluation criteria in solid tumor (RECIST) or morphologic response on computed tomography (CT) have been reported as surrogate prognostication markers. This study assessed a novel algorithm for the prognostication of liver metastasis treatment.Forty-seven patients with liver metastases from CRC who underwent liver resection after systemic chemotherapy were included. The CT values examined before and after chemotherapy were collected. The velocity of CT values (CTvΔ) was calculated, and the subjects were divided into CTvΔ_high and _low groups. Clinicopathological variables, recurrence-free survival (RFS), and overall survival (OS) were statistically compared between the two groups. In addition, the effect of the combined evaluation of CTvΔ and carcinoembryonic antigen (CEA) was evaluated.In univariate analyses, the hazard ratio (HR) for a recurrence after liver resection was relatively higher in the RECIST_stable disease (SD) or _progressive disease (PD) and the CTvΔ_low groups. In multivariate analysis, the HR was significantly higher in the CEA_high, the RECIST_SD or PD, and the CTvΔ_low groups. The RFS was significantly longer in the CTvΔ_high group. Furthermore, the combination of CTvΔ and CEA predicted the RFS and OS.Our algorithm using CTvΔ could be a useful tool to select patients suitable for liver resection of hepatic CRC metastases.
科研通智能强力驱动
Strongly Powered by AbleSci AI